Cell culture-based pandemic influenza vaccine regulatory update

Daiichi Sankyo said its Kitasato Daiichi Sankyo Vaccine Co. Ltd. subsidiary submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for a cell culture-based pandemic influenza vaccine...